Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Basal Cell Carcinoma Clinical Trials
Basal Cell Carcinoma clinical trials are recruiting across 29 cities. Here are the cities with the most active studies:
Basal Cell Carcinoma Trial Phases
12 research organizations are sponsoring basal cell carcinoma trials.
About Basal Cell Carcinoma
Basal cell carcinoma is the most common type of skin cancer, arising from basal cells in the skin. While rarely fatal, it can be locally destructive if untreated. Treatment includes surgical excision, Mohs surgery, topical therapies, and hedgehog pathway inhibitors.
Clinical trials are advancing new treatments for basal cell carcinoma. Currently, 15 studies are recruiting a combined 1,746 participants across the United States. Research is being conducted by 12 organizations including University of Rochester, Boston University, Philogen S.p.A. and 9 others.
2026 Basal Cell Carcinoma Research Landscape
As of August 2026, the basal cell carcinoma clinical trial landscape includes 15 actively recruiting studies across 29 cities in the United States. These studies are collectively seeking 1,746 participants, with an average enrollment target of 116 per study.
The research spans multiple phases of development: 7 studies are in PHASE2, 4 studies are in NA, 3 studies are in PHASE1, 1 study is in PHASE3, 1 study is in EARLY_PHASE1. The presence of Phase 3 trials indicates that some basal cell carcinoma treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 12 different organizations, including University of Rochester, Boston University, Philogen S.p.A., Dartmouth-Hitchcock Medical Center, Stamford Pharmaceuticals, Inc., and 7 others. The large number of sponsors reflects significant research interest and investment in basal cell carcinoma treatment advancement.
Geographically, basal cell carcinoma trials are most concentrated in Victor, New York (3 trials); Tampa, Florida (3 trials); Atlanta, Georgia (2 trials); Columbus, Ohio (2 trials); Houston, Texas (2 trials) and 7 other cities.
Featured Basal Cell Carcinoma Studies
Highlighted recruiting studies for basal cell carcinoma, selected by enrollment size and research scope.
Two-photon Fluorescence Microscopy of Dermatologic Biopsies
The goal of this study is to investigate the ability of two-photon fluorescence microscopy to evaluate dermatologic biopsies. The main questions it aims to answer are: • How well do two-photon fluorescence images of biopsies taken in a clinic and evaluated by a pathologist agree with conventional histology?
5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer
The investigators will compare the application of two different creams for the treatment of low-risk skin cancers-superficial basal cell carcinoma (sBCC) and squamous cell carcinoma in situ (SCCis). 5-Fluorouracil cream is currently FDA approved for the treatment of superficial basal cell carcinoma and is routinely used by dermatologists across the country and at Boston Medical Center (BMC) for SC...
L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)
Open label, randomized study in patients with LaBCC not eligible or refusing surgery or radiation therapy according to the evaluation of a local interdisciplinary tumor board. The primary objective of the study is to evaluate the efficacy of L19IL2 or L19TNF or L19IL2/L19TNF, the secondary objectives of this study are to evaluate efficacy, safety and pharmacokinetics of immunocytokines. A minimum ...
Frequently Asked Questions About Basal Cell Carcinoma Clinical Trials
Are there basal cell carcinoma clinical trials near me?
Yes, there are 15 basal cell carcinoma clinical trials currently recruiting across 29+ cities in the United States, including Victor, New York; Tampa, Florida; Atlanta, Georgia. Browse the studies above to find one at a location convenient for you.
How do I join a basal cell carcinoma clinical trial?
To join a basal cell carcinoma clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are basal cell carcinoma clinical trials free?
Yes, participation in basal cell carcinoma clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of basal cell carcinoma treatments are being studied?
Current basal cell carcinoma clinical trials are testing a range of approaches across PHASE2 (7 studies), NA (4 studies), PHASE1 (3 studies), PHASE3 (1 study), EARLY_PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 12 research organizations.
Is it safe to participate in basal cell carcinoma clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated August 29, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated August 29, 2026 · Data from ClinicalTrials.gov